Casdin Eli 4
4 · STANDARD BIOTOOLS INC. · Filed Jul 23, 2024
Insider Transaction Report
Form 4
Casdin Eli
Director10% Owner
Transactions
- Award
Common Stock
2024-07-19+1,588→ 2,752,332 total
Holdings
- 13,939,637(indirect: Casdin Private Growth Equity Fund II, L.P.)
Common Stock
- 2,744,219(indirect: By Casdin Private Growth Equity Fund, L.P.)
Common Stock
- 18,870(indirect: See footnote)
Common Stock
- 46,730,821(indirect: Casdin Partners Master Fund, L.P)
Common Stock
- 545,000(indirect: Casdin Amplify Fund, LP)
Common Stock
Footnotes (7)
- [F1]Represents Restricted Stock Units ("RSUs") that vest as to 25% on July 23, 2024 and thereafter in two equal installments on the 15th day of the last month of each remaining fiscal quarter of 2024, subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $3,750 in cash compensation for services as a board member.
- [F3]The securities are owned directly by Casdin Private Growth Equity Fund II, L.P. (the "Equity Fund II") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin"), the investment adviser to the Equity Fund II, and (ii) Eli Casdin, the managing member of Casdin.
- [F4]The securities are owned directly by Casdin Private Growth Equity Fund, L.P. (the "Equity Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Equity Fund, and (ii) Eli Casdin, the managing member of Casdin.
- [F5]The securities are indirectly owned by Eli Casdin who has voting and investment discretion with respect to the securities.
- [F6]The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.
- [F7]The securities are owned directly by Casdin Amplify Fund, LP ("Amplify") and are deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to Amplify, (ii) the GP, the general partner of Amplify, and (iii) Eli Casdin, the managing member of Casdin and the GP.